Can PGx research reporting integrate with EHR?

Yes. We already have established integrations with various EHRs. 

Which pharmacogenomic testing panels are available?

We customize reporting based on any gene panel available from Thermo Fisher and other vendors.

Do you offer customizable reporting options?

Yes. We work with your team to designing a report that meets your requirements.

Is there a provider portal to distribute reports?

Yes. Reports are delivered using our LIS provider portal.

What is the scope and purpose of PGx research services?

Emgenex offers a range of general-purpose research services suitable for various needs. The analyses provided by Emgenex are solely for educational and research use. We ensure that all advice from Emgenex is transparent and backed by citations from existing publications, which are available for independent verification. Emgenex's analysis of literature in the field of pharmacogenomics emphasizes that this area of knowledge is constantly evolving. New studies regularly emerge, either refining existing guidelines or introducing entirely new insights. It is important for researchers and other individuals who rely on pharmacogenomics reference data, including any meta-analyses produced by Emgenex, to be aware of and understand the limitations inherent in these ongoing developments.

How does research analysis differ from lab reporting?

Emgenex's PGx research analysis is separate from the laboratory CLIA reports on genetic variations. It serves as an independent literature review carried out by professional researchers. This analysis is not intended for clinical reporting purposes; instead, its aim is to efficiently present pertinent medical reference information for educational purposes to its users.